Subgroups of the clay.
Clay has its widespread applications in pharmaceuticals from ancient world to modern era. It is one of the excellent excipients present in the commercially available pharmaceuticals. Its use in many of dosage forms viz. in suspension, emulsion, ointments, gels, tablet and as drug delivery carrier as suspending agent, emulsifying agent, stiffening agent, binder, diluent, opacifier, and as release retardant have been explored in many studies. Variety of minerals is used as both excipient and as an active ingredient; among that kaolinite, talc, and gypsum are important. Their inertness, low toxicity, versatile physiochemical properties and cost effectiveness has increased its usage in pharma industries. Many minerals have its own pharmacological action as antacid, anti-bacterial, anti-emetic, anti- diarrheal agent and as skin protectant etc. Their unique structure which helps them to absorb material onto their layered sheets has opened a wide variety of applications in drug delivery. The understanding of surface chemistry and particle size distribution of clay minerals has led the pharmaceutical field in many directions and future perspectives.
- active pharmaceutical ingredient
- inherent medicinal properties
- drug delivery carrier
- synergistic effect
Usage of clay in medicine dates back to prehistorian era. Their evidences are present throughout the history from the clay pots of Nippur, Mesopotamia which gave the evidence of using clay against hemorrhages, the book “papyrus ebers” dating back in 1600 BC provided the details of using clay-based medicine for certain diseases. Many vital information on medical clay is mentioned in “On Airs, Waters and Places” written by Hippocrates (460–377 BC). One of the notable healing clay used in medicine during early days is known as Armenian bole (
The important component of clay is the clay minerals but it also comprises of associated minerals, organic, and inorganic materials. Clay can be grouped based on the geological aspects such as
Primary or residual clay
Secondary or sedimentary clay
Each clay has their own properties to distinguish themselves from the other. The classification also extends based on their geometrical shape, arrangement, and their usage. The classifications are given below.
Based on the geometry of the clay, it has been classified into four major groups and the subgroups are specified in Table 1.
|S. No||General formula||Group||Layer type|
Si4O10(OH)2M + 0.33
Saponite:Mg3(Si3.67Al0.33)O10(OH)2M + 0.33
The variation is due to the arrangement of tetrahedral and octahedral sheets, where kaolinite group has one tetrahedral sheet arranged over one octahedral sheet whereas two tetrahedral sheets arranged over one octahedral sheet in smectite group. In case of chlorite group, octahedral sheet is arranged adjacent to 2:1 layer. The clay minerals exhibit versatile properties such as high adsorption capacity, chemical inertness, thixotropy, specific surface area, ion exchange capacity, less toxicity for oral administration, swelling property justifying their wide applications in pharmaceutical industries as excipient to enhance the physiochemical and organoleptic characteristics of a drug. It also helps in aiding drug conservation, elaboration, liberation of drug into the organism. These are achieved by incorporating the clay minerals such as disintegrates, lubricants, opacifiers, binders, diluents, isotonic agent, anti-caking agents, emulsifying agent, desiccant, thickening agent, and flavor modulators. Apart from the pharmaceutical applications, clay minerals also possess a lot of pharmacological properties like anti-bacterial, anti-viral, anti-diarrheal, gastro-intestinal protector, skin protection, and a potent detoxifier. The future trend holds for the MDDS using nano-clay minerals due to their inertness and biocompatibility. More details about the pharmaceutical and pharmacological uses of clay minerals and their advancement in drug delivery system have been discussed in the following sections. Further the classification and usage of clay minerals is illustrated in Figure 1.
2. Use of clay as excipients
An excipient is an inert additive ingredient formulated along with active compound to enhance its organoleptic, physiochemical properties. Clay has been used for almost every type of excipients (Table 2). Though several investigations showed that clay interacts with the drug molecule conversely to the nature of excipients, the interaction may hinder the drug bioavailability inside the body. The co-administration of montmorillonite leads to the degradation of certain cardiovascular tonic , anti-inflammatory drug . Similarly, palygorskite and sepiolite degraded hydrocortisone and dexamethasone [11, 12]. Certain clay also affects the chemical stability of diazepam. Drugs such as phenobarbital sodium, diazepam solution, and lansoprazole show interaction with magnesite. Bioavailabity of tetracycline, indomethacin, aspirin, aspartame, ampicillin, cephalexin, and erythromycin has been drastically affected by calcium rich minerals. Clay minerals has also shown tendency to affect the drug liberation by interacting with the drugs through various mechanisms. They have shown to affect the liberation of amphetamines, analgesics, antibiotics, anxiolytics, solar protectors, and anti-histamines [13, 14, 15, 16]. The adsorption of anti-histamines, antibiotics, atropine sulfate, salicylate, hyoscyamine, hydrobromide, paracetamol, and chloroquine into periclase and brucite has been showed by Khalil et al. . These interactions have been proven useful since they are used to retard drug release. So they aid in controlled drug release and improve the Tmax considerably.
|Type of Excipient||Clay minerals||Drug used|
|As Diluent||Kaolin, talc, sepiolite, smectite, Magnesite||Slim well tablet, Quantrim, Riclasip, Riboflavin hard gelatine capsule|
|As Binder||Gypsum, hydroxyapatite, kaolin||Kaolin-Eudragit 30 in many tablets|
|As Disintegrant||Palygorskite, kaolin, sepiolite||Hydrochlorothiazide|
|As Granulating agent||Kaolin, anhydrite, periclase||Granules of NaCl and kaolin in Tablets preparation|
|As Emulsifying and wetting agent||Kaolin, palygorskite, smectites, sylvite, halite||Sulfur ointments.|
|As Suspending agent||Kaolin, palygorskite, smectites, sylvite, halite||Toxiban, morphine suspensions|
|As Drug delivery carrier||Natural MMT|
Acid treated MMT
Kaolinite pillared MMT
Kaolinite-PVP-Sodium laural sulphate
|Diclofenac sodium, chlorhexidine, gallic acid, promethazine|
Ciprofloxacin, Ag-Nanoparticles of Tetracycline, gentamycin, theophylline, nitric oxide, acetyl salicylic acid, Ibuprofen
5-amino salicylic acid, binase, tetracycline, amoxicillin, paclifaxel
Doxorubicin, aspirin, curcumin,
Vancomycin, 5-flurouracil, hydrocortisone
2.1 Clay in biphasic liquid formulation
2.1.1 In suspension
Excipients are required in the biphasic system in order to obtain proper wetting and to maintain stability of the formulation. In order to overcome the hydrophobicity of the drug and to aid in dispersion, clay minerals are added to the suspension as wetting agent. Sulfur ointment is prepared by blending kaolin with sulfur dispersed in oil phase . The usage of bentonite as a wetting agent in foundation creams is also documented . The clay also helps to maintain the stability by acting as suspending and anti-caking agent. They prevent sedimentation, changes in dispersion property, and flocculation. The criteria of selection of suitable suspending agent depend on compatibility, appearance, source, cost, and pH tolerance. The properties of the suspending agent including high viscosity at low shear rate, temperature, and storage tolerance, should not be affected by electrolyte or pH and be non-toxic. The formation of aggregates which in turn leads to the caking of solids would be the problem of suspension at the higher concentration. Reduction in the particle size or viscosity could not prevent caking. Caking can be prevented by flocculation and electrostatic stabilization [19, 20]. Kibbe showed that the increase in the stability of suspension using kaolin and talc as suspending and anti-caking agent. A suspension of pectin containing MAS dispersed in water along with kaolin under constant agitation at 70°C to which pectin was added, CMC was used to modify viscosity . The usage of MAS and its four types (IA, IB, IC, and IIA) as a suspending agent has been commercialized and recognized by pharmacopeias, as they do not affect the pourability or spreadibility of the suspension. Sarfaraz  reported the usage of magnabrite S (10 mg/ml) and magnabrite K (15 mg/ml) in bismuth sub-salicylate suspension in which smooth gel was obtained as a final product. The usage of MAS (veegum HV) as gelling agent was studied by Sarfaraz  and Vanderbilt report . Vanderbilt report also suggested that the gelling property of veegum HV was affected by acids and improved by alkalies. An antacid suspension with veegum HV was prepared by Sarfaraz  using xanthan gum to modify viscosity. Schott  optimize the concentration of bentonite as suspending agent and concluded that the concentration between 0.5–5% w/v was suitable for formulations. Bismuth subnitrate suspension produces good flocculation at 1.7% w/v of bentonite.
Many semisolid formulations use phyllosilicate as suspending agent due to their good adsorptive capacity which can be further improved by heating . In many semisolid topical formulations, surface activated kaolin is added to enhance the stability and water miscibility of hydrophobic drug. Pharmaceutical preparation such as kaolin and morphine oral suspension BP, Toxiban suspension use kaolin as suspending anti-caking agent. The effect of crystallinity of kaolin on aqueous suspensions was studied by Ndlovu et al. Due to their dominant negative charge and ability to create permanent electrostatic repulsion justify kaolin use in suspension. The effect of non-ionic surfactant noigen RN10 (polyethylene alkyl phenyl ether) on kaolin wettability and stability was also studied. Clay can also help in stabilizing the suspension by having the effect on its rheological property since viscosity determines the rate of sedimentation according to stokes law. The different types and amount of clay are used to determine the final rheological property of the suspension. Dispersions showing dilant behavior contains 1:1 clay minerals and the pseudoplastic behavior is exhibited by 2:1 clay minerals. The commercialized MAS is a fibrous 2:1 clay containing blends of montmorellonite and seponite [6, 24, 25]. A combination of polyethylene glycol with hectorite improved the suspension stability [26, 27]. The modified hectorote such as quaternary C18 hectorite, Steralkonium hectorite is used in organic media to control viscosity .
The use of clay along with polymers has shown beneficial effect on their rheological properties, which has been demonstrated in griseofulvin suspension with MAS and sodium alginate by Dechow et al.  in sulfamethoxazole/trimethoprim suspension. The synergistic effect of CMC on properties of MAS such as viscosity, electrolyte tolerance, smooth flow property has led to the development of Veegum PLUS . A similar synergism has also found in xanthan gum [31, 32].
2.1.2 In emulsion
Clay minerals are also added to pharmaceutical emulsion to prevent coalescence, creaming, phase inversion, breaking, and flocculation. This is due to their ability to wetted by the two liquid phases and be present as a barrier to prevent phase separation. Flocculation can be prevented by clay material due to their zeta potential. The stability of the emulsion is improved with increase in contact angle. They also used in the mechanical production of emulsion by acting as a surface acting agent which can bind in the interfacial layer but do not reduce the interfacial tension and interface. Due to its higher surface area, talc has been used as a emulgent in the cosmetic preparation . The use of bentonite as emulsifying agent is familiar throughout the cosmetic industry. A nail enamel cream contains bentonite as an emulsifier was prepared by Carter . He also proposed specific method of the cream preparation. Vanishing creams and skin protectants also use bentonite in a concentration of 2.5% w/v as emulgent . In order to aid in easy application and adherent effect on the skin surface, clay minerals are added in corn and callus emulsion . They are also added to hand creams as a thickening agent to retain better moisture control. The viscosity of the liquid eye liner formulation is maintained by addition of veegum . Purified bentonite (Polargel NF) has been used as an emulsifying agent in cleansing lotion with HPMC and benzoyl peroxide. This has also been prepared as a cream by the addition of viscosity building agent (Carbomer) . An anti-acne cream emulsion is prepared by using MAS . MAS is also incorporated in cream emulsions for burns, methyl salicylate (analgesic effect), astringent zinc oxide, zirconium oxide and in zinc undecylenate lotions as a emulsifying agent . Certain vitamins enriched skin creams also use MAS as emulsifier . The synergic effect of xanthan gum along with MAS has been seen in zirconium oxide lotion . Wenninger et al.  showed the usage of palygorskite as an emulgent (2–5% w/v). The presence of Na+ and K+ ions in halite and slyvite and their ability to control micelle size enumerate their use as emulsifying, thickening and anti-caking agent . The long-term stability of pickering emulsions (where dodecane is used as oil phase) is improved by addition of kaolin (15% w/v) without any other additives .
2.2 Use of clay as an excipient in solid dosage forms
2.2.1 As diluent
Pharmaceutical oral preparations contain excipients such as diluent, flavorant, binder, disintegrant, pelletizing agent, granulating agent, sweetening agents, film coating agent, lubricant, and desiccants. Each excipient has its own influence on the formulation without interfering with active drug. It enhances the organoleptic and physiochemical property of the formulation. Diluents are selected based on the water solubility and bioavailability of active drug. Formulations with less water soluble drugs are incorporated with water soluble diluents and vice versa. Kaolin exhibit non-hygroscopic nature and low moisture content which determines its effectiveness as a diluent, as high moisture content may affect compressibility, physical and chemical stability of the formulation. Physiochemical parameters of kaolin have a direct impact over compressibility of the formulation . The usage of kaolin as excipient for their adsorbent capacity has to be properly maintained since high adsorbent capacity can lead to less bioavailability of the drug [38, 39, 40]. Diluents are mainly added to the formulation to bulk up the volume and to facilitate easy compression. Diluents account for the 90% in low dose formulation. Product such as slim-well and quantrim use kaolin as bulking agent whereas mecysteine hydrochloride (Gastro resistant tablet) has heavy grade kaolin. Riclasip and co-amoxyclav DST grunenthal uses kaolin as adjuvant . The use of kaolin with metronidazole (antibiotic and antifungal drug, Riazole) reduces its bioavailability, release characteristic and diffusion of drug inside the body . The absorption of D, L-phenylalanine (analgesic and anti-depressant) onto the slurry of colloidal kaolin was showed by Bonner and Flores  through in vitro gross adsorption chromatographic study. Kaolin also affect the bioavailability of drugs like phenytoin (anti-seizure drug), promethazine-HCl (sedative and antiallergic drug), chloroquine (anti-malarial), propranolol (vasodilator), quinidine sulphate (cardiac antiarrhythmic drug), phenothiazines (trifluoperazine, fluphenazine, perphenazine, and thioridazine), guanethidine and hydralazine (antihypertensive drugs), procainamide and verapamil (antiarrhythmic drugs) with antidiarrheal Kaopectate® drug [44, 45, 46, 47, 48, 49]. It has been reported that Langmuir isotherm was followed in drug absorption by kaopectate which extent the bioavailability but the rate of drug availability is retarded. The double layered adsorption pattern of mebeverine hydrochloride (antispasmodic drug) with kaolin and added electrolytes again follows Langmuir isotherm was studied by Al Gohary. These types of interactions of kaolin can be prevented by increasing the ionic strength of the drug solution and with the presence of –NH2, –O–, and benzene ring, as chelating ligands led to the interaction. The presence of di-aromatic ring in naproxen (anti-inflammatory drug) and siloxane surface of kaolin are responsible for their interaction . On other hand, the absorption of ampicillin and warfarin (anticoagulant) with antidiarrheal kaolin-pectin is shown to be unaffected by kaolin [51, 52], which was again conformed by Khalil et al. . In fact, the use of kaolin as diluent in water soluble cationic riboflavin (vitamin B2) has improved the release rate of drug from hard gelatin capsule than any other diluents used. The rate of drug release is pH dependent . The sustained release formulation of pyridoxine hydrochloride (vitamin B6) was prepared by using kaolin as diluent . Vitamin drugs degrade easily in the presence of high moisture content since kaolin exhibit low moisture content the formulation containing vitamin B1 (thiamine) and Vitamin C (ascorbic acid) is more stable on addition of kaolin than other additives [56, 57].
2.2.2 As binders
Binders help to maintain the physical integrity of the solid dosage form owing to their mechanical strength. They also play a vital role in granulation, tableting, encapsulation by acting as a homogeneous dispersed matrix for adhesion of all material in the formulation. On this context, the mixture of kaolin-Eudragit (8% w/w) has been one of the good binders for tableting process. Eudragit is a poly ester based resin which exhibit hydrophilicity and does not get affected by varying pH and also the presence of kaolin help to obtain a uniform polymeric dispersion by differentiating water insoluble and hydrophilic particle within the system. Irrespective of their physiochemical properties, hydrophilic drugs are also blended with low water soluble drug in the kaolin-Eudragit formulation due to their larger permeability. Based on kaolin concentration they can also be used as film coating agent [58, 59]. Minerals like periclase, calcite, and magnesite are added as binders to increase the stomach pH .
2.2.3 As disintegrant
The release of drug from the formulation once it reaches inside the body mainly depends on the nature of the disintegrant used during formulation. Disintegrant facilitate breakdown of solid dosage form into smaller particulates. Poor solubility, poor gel forming capacity, good hydration capacity, good molding, flow property, and should not form complex are the required criteria for disintegrants. Both swelling property and ability to decompose at acidic environment of smectite made its use as a disintegrating agent. The presence of negative charge and ability to produce permanent negative surface charges helps kaolin as a disintegrant [61, 62]. A mixture of kaolin with surfactant and cellulose when added to formulation which already has starch as a disintegrant increased its shelf life over a long period of time . Later, the use of kaolin as a positive effect than starch as a disintegrant has been proved .
2.2.4 As pelletizing agent
Kaolin proved its efficiency over bentonite by forming pellets which show faster disintegration while the pellets formed by bentonite was only erodible not disintegrable . Kaolin along with biopolymer increase the drug dissolution rate of hydrochlorothiazide by forming pellets that rapidly disintegrated into the dissolution medium . The primary aim of pelletizing agent is to form microspheres of uniform size which can be compressed into tablets or filled into capsules that rapidly disintegrates inside gastrointestinal drug where each pellet act as sustain formulation [67, 68]. Kaolin as a pelletizing agent in comparison with bentonite, talc, veegum and bentonite produce pellets with maximum yield, desirable size and smooth pellets on addition of SLS (5%) over the others . The beneficial effect of crospovidone (5% w/w) and kaolin (25% w/w) with lactose as pelletizing agent for enhancing roundness and sphericity of pellets was demonstrated by Kristensen et al. . The drug dissolution rate of riboflavin was higher with kaolin than microcrystalline cellulose and lactose . Desirable size range and sphericity can be obtained by incorporating high kaolin content. Aerosil 200 (5%) along with kaolin (45%) has huge positive impact on sphericity of pellets . The granulating agent is added to the formulation to improve flow property, density, appearance and uniform drug content, they also aid in compressibility of oral formulation. Wet and dry granulations are most commonly used method of granule preparation. Wet granulation involves wetting, nucleation, coalescence, breakage, and attrition process whereas dry granulation involves direct compression or slugging [71, 72]. Granules of desirable strength, size, cohesion, and uniformity can be produced by mixture of kaolin and sodium chloride (10% w/w) in wet granulation process. The comparative study of kaolin with polyethylene glycol and polyvinyl alcohol as a binder in calcium chloride showed kaolin PVA mixture gave larger yield and size than PGA kaolin mixture .
2.2.5 Aid in solubility, dissolution, and lubrication
Kaolin also helps to convert drugs form their crystalline to amorphous state to improve their solubility, dissolution rate, and bioavailability [74, 75, 76]. Kaolin was added to ibuprofen in order to convert it to amorphous salt from its crystalline form to facilitate higher dissolution and bioavailability in comparison with standard. Halite can be used to control osmolarity of the solution due to their high solubility in water . Amorphization is inversely proportional to the kaolin concentration . Clays are also used as desiccants due to their hygroscopic nature. Talc is used as lubricant and to prevent adhesion of powder to the compression pistons due to their soft and unctuous nature . They are also used as flavorant to mask the taste of the formulation.
2.2.6 As coating agent
The use of film coating additive enhance the organoleptic characters of solid dosage form, helps in maintaining stability and control drug release profile [79, 80]. The decrease in the rate of drug release of diphenhydramine chloride, theophylline, and pseudoephedrine hydrochloride pellets coated with Eudragit on addition of kaolin (3:1 of resin) was studied by Ghebre-Sellassie et al. . Kaolin is also added to the film coating of hypericon and kollicoat IR. Kaolin incorporated on the outer shell of triple pressed dyphylline coated tablets showed control release .
2.2.7 Enhancer of organoleptic properties
The organoleptic property of a drug can be modified on addition of excipients like pigments and opacifiers into tablets, capsules, syrups, and topical creams. These are necessary to avoid confusion while administering multiple medications and for easy identification of different dosages and help to protect the drugs from photo-oxidative damage. Clay minerals (calcite, rutile, hematite, and magnesite) possess a wide range of color from red, green, black, yellow, and white. Coloring E171 is most used pigment which is a synthetic analogue of white zincite. Synthetic rutile is used on sunscreen lotion as opacifier.
3. Use of clay as an active ingredient
Clay minerals also has its application as active ingredient in pharmaceutical preparation due to their ability to act as antacids, antianemics, mineral supplements, gastric protectors, laxative, antidiarrhoeaics, antibiotics, antiviral agents, wound dressing agent, detoxifier, antitumor agent, anti-inflammatory, and tropical analgesic.
Acidity is caused by excess secretion of HCl in the stomach due to various conditions. Clay minerals overcome acidity either by neutralizing hydrochloric acid or by decomposition of minerals by absorbing H+ ion on to their surface. Thus, restoring the stomach pH to 7 from 1.5 to 2.5. An effective antacid must increase the pH by three to four units and decrease the free acidity, which is seen in clay minerals like calcite, magnesite, periclase, brucite, and hydrotalcite. Whereas palygorskite, sepioite, montmorillonite, and saponite neutralize acidity by absorbing H+ ion onto their surface. Their usage also can lead to certain side effects such as renal silica calculi, constipation in case of over accumulation of Ca2+ since they form insoluble hydrate phosphate and Mg2+ ion produces laxative effect but these effects can be avoided by using different mineral compositions. This combination has also an advantage of sustaining the drug release for example the co-administration of gibbsite with brusite prolonged its antacid action since brusite is fast acting and gibbsite is slow acting antacid .
3.2 Wound dressing agent
Wounds characterized by skin abrasion and vascular damage can lead to microbial invasion, toxicity, and even hemorrhagic shock due to uncontrolled bleeding. This is countered by our body homeostatic response through coagulation of blood which prevents bleeding. Hemostasis follows sequential steps like: (1) thrombin formation is initiated, (2) activation and platelet aggregation (amplification), and (3) fibrin formation to stabilize the platelet clot (propagation). Hemostatic agents provide a physical mesh-like layer which aid in amplification and propagation steps of hemostasis thus leading to platelet aggregation and coagulation. The negative surface charge of kaolin at blood and plasma pH has a drastic effect on its blood clotting potential. The activation of blood coagulation factor XII to its active is done by kaolin on contact with blood and plasma. The active form of factor XII in turn activates factor XI and pre-kallikrein which helps in preventing bleeding. Therefore, many wound dressing products contain kaolin as topical hemostatic agents (Quickclot combat GauzeXL, Quickclotinterventional™) [83, 84, 85, 86, 87].
3.3 Peptic ulcer
Peptic ulcer is characterized by thinning of mucosal layer of the stomach due to the mucolytic activity of stomach enzymes, in order to reduce gastric irritation and provide a barrier for mucosal layer several clay minerals are used for their high sorption capacity and non-toxicity. These clay minerals absorb all the gases, toxins, bacteria and even viruses and reduce gastric secretions. They also act as protectants decreasing the glycoprotein degradation in the stomach. But their non-specific action has led to their minimal usage. Even though smectites prevent the pepsin damaging activity over the mucosal layer, their very less time of action and tendency to get degraded in the acidic medium has been a disadvantage but kaolin can be stable and show very low dissolution even at very less pH. They are taken as tablets, suspensions, or powders orally. They dissolve easily in the acidic medium aiding in their easy elimination and absorption [82, 88, 89, 90]. Kaolin due to their higher sorptive capacity delay gastric emptying and intestinal transit by enhancing triacylglycerol hydrolysis and promoting the intestinal uptake of non-esterified fatty acid and glucose .
3.4 Anti-diarrheal agent and anti-emetics
Kaolin has been used as an API in formulations for gastrointestinal like ASDA stomach upset tablets, Entroclam, or Boots kaolin [92, 93]. Diarrhea is caused by various factors like allergy, bacterial infection, intoxication, and low efficiency of intestinal sorption. It is characterized by increase in fluidity and frequency of evacuation. Anti-diarrhoeaics agents must have very good absorption capacity of excess water as well as gases in the digestive tracts. Activated clay minerals like kaolinite, palygorskite, sepiolite, and montmorillonite can be used against diarrhea for their high sorption capacity. They also prevent diarrhea by forming in soluble salts through release of Ca2+ (calcite) and Al3+ (gibbsite) ions [94, 95, 96, 97]. Pharmaceutical products such as kaolin/pectin (Kaopectate®) and Kaomix® suspensions, kaolin Antacil®, Sainsbury’s Diarrhea relief® and Treda® tablets contain kaolin as active ingredient against diarrhea due to hydrophilicity, surface area, microporosity, water osmotic and retention property as well as its antibacterial and antiviral effect (e.g., Norwalk and rotavirus, salmonella, Shigella and
3.5 In anemia and inflammation
The use of clay minerals extents till its usage in disease like anemia. Anemia is caused due to less production red blood cells which may be due to less availability of Fe2+. This can be treated with melanterite which is rich in Fe2+ ion and readily soluble in water. They are given as oral solution; these ions on reaching blood plasma convert into ferric ion by binding with a transferrin and globulin β. The excession is stored in liver, spleen, and bone marrow. Some are excreted through urine, gall bladder, and bile duct. Orally administered halite, epsomite, brucite, periclase, calcite, hydroxyapatite, magnesite, sylvite, melanterite as tablets provide ions such as Ca2+, Na+, Ca2+, Fe2+, K+, PO43−, and Mg2+ which are very much essential to our body . Inflammatory response in our body is triggered to produce white blood cells and their mobility towards the injured site from infection through antigens or other harmful micro-organisms. Swelling, redness, pain, and heat are the main symptoms of inflammatory response. Lopez-Galindo and Viseras  presented the use of kaolinite poultices as anti-inflammatory drug, since they can absorb the excess fluid content near the infected tissue, which reduces pain and congestion considerably. They also aid in skin cooling by acting as a heat retention agent. Proper care of temperature must be taken while administering these dosages since it can have an effect over its therapeutic action [103, 104, 105, 106, 107, 108].
Minerals like sulfur, goslarite, borax, zincosite, chalcanthite, zincite, and alum are highly corrosive and toxic to pathogens in higher concentration hence they can be used as an antiseptic or disinfectant. They are also used as an astringent (chalcanthite), bacteriostatic agent (borax), fungicide, hemostatic agent (alum), and for skin damage. The bactericidal activity of clay extents to many drug resistant bacteria like
Kaolin is found to influence superoxide radicle generation by immunocompetent carcinoma blood cells of Lewis lung in mice this opens a huge area of application for kaolin usage in restorative cancer treatment. Their antitumor property has made it a potential candidate under investigation [92, 100, 110, 111, 112]. Minerals like zincite, talc, rutile, hydrozincite, smithsonite, kaolinite, and smectites are used as an protective agent in skin to prevent against certain external environmental condition and pathogens. They have suitable properties like high sorption, non-cytotoxic, little antiseptic and bactericidal as discussed above. They are used as creams, powders, and ointments (REINOL drygard, DP1, kerodex 51, etc.). They are also incorporated in sunscreen formulation to prevent against harmful UV-A and UV-B. Minerals like rutile and zincite absorb, reflect, and scatter the radiation but they may cause skin damage by photocatalytic action this can be overcome by using kaolin as protectant since it shows higher UV protection capacity due to the high Fe2O3 content. Kaolin also used to absorb excess moisture, oily secretion, surface lipids, and superficial toxin from the skin surface to prevent acne, blackheads, bacterial, and fungal infections. Even they are used for insect bites to give relieving effect .
3.8 Skin protectant
Sulfur containing minerals are extensively used as keratolytic reducers as they are effective against dermatitis, eczemas, and psoriasis. Sulfur reacts with cysteine in the presence of keratinocyte producing hydrogen sulphide which breaks down keratin. Dandruff is treated with cadmium sulphide shampoo. The less common adverse effect of sulfur applied as topical cream is an added advantage . Isotonic collyrium contains dissolved halite which is used as decongestive eye drops for treating eye dryness, irritation, and other ocular discomforts.
4. Use of clay as a drug delivery system
An effective drug delivery system is essential for achieving proper bioavailability of the drug administered. Recent studies have paved way for many new modified drug delivery system that has led to sustained drug deliver, controlled drug delivery, and site-specific drug delivery (Table 2). Each has its own mode of release and application in the body. The modification can be made only through excipients employed. The proposed excipients must possess good delivery efficiency at the same time have inertness, easy availability, cost effective, and low toxicity. Thus, all these are readily available in clay minerals and their physiochemical properties make them a potential candidate for design of MDDS. Clay minerals either in their native form or modified in certain way to improve their physiochemical properties to aid their use as a drug carrier for delivering system.
4.1 As release retardant
Kaolin (1:1) and smectite (1:2) are the most common used clay groups in the design of MDDS due to their geometrical structure. The side effects like short half-life and requirement of frequent dosage in diclofenac sodium (NSAID) can overcome by intercalating it with MMT that prolong drug release. The toxicity of topically administered chlorhexidine (antibiotic) can be prevented by using Na-MMT as a drug delivery carrier. The photolytic damage of promethazine (antihistamine) when administered topically is reduced by intercalation of drug with Na-MMT. The in vitro activity and controlled release of paclitaxel (anticancer) is increased by intercalation with Na-MMT and coating with chitosan (biopolymer). Gallic acid has various properties like poor solubility, permeability, and faster metabolism which make it difficult for dose administration and drug release. The idea of Gallic acid with MMT was suggested and carried to and characterized the drug release profile which showed promising results. A dermal patch prepared using MMT-Na loaded with silver (antimicrobial agent), lidocaine (mild analgesic), and betaine hydrochloride showed a controlled release of lidocaine. The controlled drug release of metformin with Na-MMT was studied in order to reduce the side effect and dosage of drug. But the study concluded that the drug release was highly pH dependent and needed further analysis. MMT enhanced the antibacterial activity with TiO2 coated with alginate against both gram positive and negative bacteria. Mesalazine (5-Aminosalicylic acid) must reach colon to show its therapeutic action against Crohn’s disease but mesalazine is highly absorbed in the acidic environment of stomach. This can be altered and slow drug dissolution in stomach was achieved using MMT-Na encapsulated into alginate beads. Acidification improves clay surface area and increases pores for sorption. These acidified clays was used as a carrier to deliver ciprofloxacin, the acid treatment retarded the drug release due to the changes in the interlayer charges, this also provided insight on the usage of interlayer charge modifications of the clays can be a useful phenomenon for drug delivery. Silver nanoparticles are also loaded with modified clay and their antibacterial activity is characterized and a comparative study between modified and unmodified clay hybrid for their loading capacity and antibacterial activity against
4.2 Clay-biopolymer combination
Biopolymers can also influence drug delivery by encapsulation or by surface coating over the formulation and help in controlled drug delivery. Hence, clay hybrids are coated with biopolymers to enhance their action. Clay hybrid and biopolymer (chitosan) showed synergistic effect on loading efficiency and drug release of 5-aminosalicylic acid. The oral bioavailability of oxytetracycline (broad spectrum antibiotic) was improved by loading over chitosan-MMT carrier. The cytotoxicity of chlorohexine to fibroblast was reduced by preparing a film carrier made of MMT-chitosan complex. The prepared topical formulation showed a controlled release of drug and reduction of cytotoxicity was also reported. MMT-chitosan glutamate composites also reduced the cytotoxic effects of silver sulfadiazine (skin burns). The result show that electrostatic interaction of MMT with polymer helps improving the drug absorption and the increase an antibacterial activity of formulation was also noted. Apart from chitosan, other biopolymers have been used to prepare drug carriers. A combination of guar gum-MMT hybrid was used to prepare a controlled release formulation of ibuprofen to reduce their side effects on intestinal tracts. The need of frequent dosage of venlafaxine (anti-depressive drug) was reduced by preparing beads with crosslinking of sodium ALG with drug-MMT in CaCl2. Olanzapine (schizophrenia and bipolar disorder) was incorporated into different polymer composition and their drug release at different pH was studied and the results were in comparison with the marked drug and an effective controlled release was obtained by cloisite-drug with a blend of polymers (Alginate and xanthan gum). The solubility of curcumin (anticancer, anti-inflammatory and antibacterial agent) can be increased by dispersing the drug with CMC and loading into MMT, the role of MMT here is to improve the drug release in the acidic environment. A transdermal DDS was prepared from MMT nanocomposite, pectin, and methyl cellulose which is used to load ketorolac (NSAID). The formulations showed immediate release of drug from the nanocomposite layer but the increase in MMT showed controlled drug release. The PLA microspheres of 6-mercaptopurine (anticancer drug) with MMT showed a faster release rate and increased the drug solubility. The presence MMT also helps to control the drug release. The performance of a pH dependent swelling polymer (poly acrylamide-co-maleic acid) was improved by the addition of MMT hybrid, it exerted a control over the caffeine drug release even during sudden pH transitions. A prolonged oral DDS was prepared for 1,3,4-oxa(thia)diazole (antifungal, antibiotic, analgesic and anti-inflammatory agent) by preparing nanocomposite using MMT hybrid. A site specific DDS was developed using MMT-polymer hybrid for anticancer treatment by co administration of doxorubicin and methotrexate with ciprofloxacin (antibiotic). Specificity of the DDS depends on the pH of the tumor cells. The results showed that the entire three drugs exhibit delayed drug release, where the anticancer drugs showed similar release profile and ciprofloxacin showed a different release profile at pH 5.8 and 4. PLGA is another biopolymer which is extensively used as carrier for drug administration. A double emulsion of atenolol with PLGA and MMT was prepared by Lal and Datta to increase the half-life and dissolution rate of the drug. The result suggested a controlled drug release in both acidic as well as basic medium with marking changes in the acidic medium. The hydrophobic drug (dexamethasone) was also intercalated with PLGA and MMT by Jain and Datta to lower the risk of side effects and achieve effective plasma concentration at minimal dosage. PLGS-MMT nanocomposite is used as a carrier for insulin. In vitro studies by Lal et al. suggested the protective nature of MMT even in acidic conditions and also they do not affect the HEK-293 cells growth. A triblock (PCLA-PEG-PCLA) copolymer hydrogel of MMT-gemcitabine (anticancer) was prepared for the intravenous administration of drug since the drug is metabolized rapidly and require high dose. In vitro drug release studies suggested that MMT significantly reduced the drug release and the side effects. Nanocomposite of MMT hybrid with HEMA was used to modify the dissolution profile of paracetamol by Bounabi et al. The inclusion of MMT improved the drug encapsulation of paracetamol in the PLA-drug nanocomposite. A site specific DDS was prepared for doxorubicin was prepared using MMT hybrid with PE-5000/PEG750 polymer. Organoclay (MMT-PVP hybrid) nanocomposite was used to encapsulate copaiba oleoresin a natural derivative used against endometriosis. The nanocomposite showed effective controlled drug release at acidic pH. A polymeric composite (PVA, CS and MMT) was prepared to encapsulate 5-flurouracil (anticancer) in order to compensate its poor oral absorption and rapid metabolism. The results also indicate that the drug loading efficiency and drug release depends on the MMT concentration. Clay minerals like halosite and fibrous phyllosilicates have MMDS application due to their tubular and ribbon shaped structure. For example, the Hal nanotubes can adapt to any morphology making them used for wide variety of applications in MDDS. Various antibiotic like ciprofloxacin, chlorpheniramine, tetracycline, diphenhydramine has been loaded on to the hal nanotubes and investigated. Cationic exchange capacity and pH determines the drug loading capacity on to the hal nanotubes. Thermodynamic equilibrium also affect the drug loading in hal nanotubes as in the case of isoniazid (antituberculosis drug). The immobilization of binase (RNase enzyme) which is used in the genetic treatment of cancer was done and an enhanced anticancer property was reported. Vancomycin and breviscapine has been loaded on to hal nanotubes by vacuum cycle and the resultant complex showed a sustained release of drugs. Amoxicillin loaded onto Hal nanotubes are combined with biopolymers (PLGA and Chitosan) and the drug release was studied the results suggest a sustained release is obtained on both formulations with and without biopolymers than biopolymer-drug complex. PMMA was coated onto paclitaxel-hal nanotube complex to improve the anticancer activity of the drug. Volatile drugs are also adsorbed onto the clay minerals which help in preventing the evaporation of those drugs and retaining their therapeutic action. The volatile drug absorption of MMT, hal nanotubes and palygorskite was evaluated by loading carvacrol (treat skin lesions). Good adsorption was seen in palygorskite. Veegum HS and sepiolite improved the solubility and dissolution rate of praziquantel (treatment of schistosomiasis) in both acidic and basic environment. Higher dissolution was achieved by oxaprozin (Non-steroidal anti-inflammatory agent) on mixing it with clay hybrid of palygorskite and sepiolite modified with cyclodextrin. Curcumin was loaded with both functionalized clay and cellulose-MMT complex to improve its site specific action and synergic effect on wound healing. A phospholipid nanocomposite of hal nanotubes was prepared to achieve a sustained release of doxorubicin. The electrostatic interaction and intermolecular hydrogen bonding between palygorskite and chitosan was studied for its usage as a drug carrier for 5-aminosalicylic acid. Sepiolite is also used with chitosan as drug carrier for tetracycline and cefazolin. In vitro studies show the swelling of gel is facilitated by chitosan whereas the drug release id controlled by crosslinking of polyvinylacryalate (PVA). The synergistic effect of hydroxypropylmethylcellouse acetate succinate along with atorvastatin and celecoxib for colon cancer is due to their effective solubility in basic pH. The controlled release of drug in colon is achieved by the preparing microspheres of hal nanotubes and HPMCAS loaded with anticancer drugs.
5. Pharmaceutical clay in share market
The clay minerals are exported worldwide for their various applications in construction and pharmaceutical preparations. Based of the application the clay mineral export is classified as tableware, sanitary ware, medicinal applications. The key minerals are bentonite and kaolin which accounts for major export. Bentonite is exported as sodium, calcium and sulfur bentonite. The global market demand of bentonite (Figure 2a and b) was 22.68 million metric ton by 2016 and estimated to be 25.15 Million metric ton by 2021 with a CAGR increase of 2.12%. The global market share of bentonite by 2017 was 1.43 billion and estimated to be increasing scale due to the market demand and increase in the applications of clay minerals. The major region of export is classified as Asia Pacific, North America, Europe and Rest of the world with Asia and North America accounting for most. The major companies exporting clay minerals are Ashapura groups (India’s major exporter), Imerys(sandB), Taiko group, Huawei Bentonite, Theile kaolin company, Kaolin A.D, J.M.Huber, Daleco resources.
6. Conclusion and outlook
From the moment of discovery clay minerals have been immensely useful to human life in both ceramic and health. Their usage in health care has made it a essential compound in many pharmaceutical preparations. Their inertness, low toxicity, versatile physiochemical properties and cost effectiveness has increased its usage in pharma industries. At the same time precautions must be taken while incorporating higher doses of clay and while co-administering clay with drug. Since some clay has been reported to reduce the efficacy and bioavailability of certain classes of drugs like antacid and in higher doses it might cause tissue toxicity. The understanding of surface chemistry and particle size distribution of clay minerals has led the pharmaceutical field in many directions and future perspectives. Their unique structure which helps them to absorb material onto their layered sheets has opened a wide variety of applications in drug delivery. Their ability to control and alter drug release profile can been exploited in many ways to design a effective drug delivery system. Further advancements in nanotechnology have helped to synthesize and modify this clay mineral to enhance their physiochemical properties and their usage as excipient. Though clay and their minerals are used in its natural state for drug delivery, some require additional modification for their usage and this modification plays a key role in determining the economical aspect of drug designing. The development of machinery which helps us to understand better about various unknown properties of clay minerals which were not understood before will aid us to utilize clay minerals in various other applications.